SAMANTHA LEVERING: Open Payments
NPI 1194476036 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$503 in 25 payments from 19 companies in 2025. Trend: 2023 $1,053 · 2024 $879 · 2025 $503
Food & beverage: $503
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 2 | $55 |
| ABBVIE INC. | 2 | $53 |
| Incyte Corporation | 2 | $47 |
| Adaptive Biotechnologies Corporation | 2 | $46 |
| Legend Biotech USA Inc. | 2 | $40 |
| Astellas Pharma US Inc | 2 | $29 |
| Janssen Biotech, Inc. | 1 | $25 |
| Syndax Pharmaceuticals, Inc. | 1 | $22 |
| Alexion Pharmaceuticals, Inc. | 1 | $21 |
| Acrotech Biopharma Inc. | 1 | $19 |
Products named: CARVYKTI, VENCLEXTA, JAKAFI, clonoSEQ, Vyloy, Fabhalta, SCEMBLIX, REVUFORJ.
Industry payments across IN — which companies pay providers there.
